ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Mild Palladium-Catalyzed CꢀH Alkylation
Using Potassium Alkyltrifluoroborates in
Combination with MnF3
Sharon R. Neufeldt, Cydney K. Seigerman, and Melanie S. Sanford*
Department of Chemistry, University of Michigan, 930 North University Avenue,
Ann Arbor, Michigan 48109, United States
Received April 1, 2013
ABSTRACT
A Pd-catalyzed method for ligand-directed CꢀH alkylation with organoboron reagents is described. The combination of potassium organo-
trifluoroborates, MnF3, and a PdII catalyst effects pyridine and amide-directed CꢀH alkylation. These reactions proceed under mild conditions
(25ꢀ40 °C in weakly acidic media), are effective for installing methyl and 1° alkyl groups, and do not require promoters such as benzoquinone.
Palladium-catalyzed CꢀH functionalization is an atom-
economical alternative to more traditional cross-coupling
reactions for the formation of CꢀC bonds.1 Numerous
reports have demonstrated Pd-catalyzed ligand-directed
CꢀH arylation using diaryliodonium salts, aryl halides,
and arylboronic acids.1 In contrast, examples of analogous
Pd-catalyzed ligand-directed CꢀH alkylations remain
much more limited.2ꢀ6
Organoboron compounds are particularly attractive
reagents for CꢀH alkylation due to their low toxicity,
low cost, and synthetic accessibility.7 Seminal work by Yu
established the feasibility of PdII/0-catalyzed CꢀH alkyla-
tion with alkylboronic acids.2 However, these transfor-
mations have limitations with respect to generality, practi-
cality, andefficiency.2 For example, relativelyfewdirecting
groups are effective, and extensive optimization of addi-
tives, solvent, and oxidant is typically required for each
substrate class. In addition, these transformations gener-
allyrequire high temperatures(g100 °C), along withbases,
silver salts, and other additives/promoters. In particular,
stoichiometricquantitiesof benzoquinone(BQ) are used in
all such reactions reported to date.
(1) (a) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107,
174. (b) Kakiuchi, F.; Kochi, T. Synthesis 2008, 3013. (c) McGlacken,
G. P.; Bateman, L. Chem. Soc. Rev. 2009, 38, 2447. (d) Chen, X.; Engle,
K. M.; Wang, D.-H.; Yu, J.-Q. Angew. Chem., Int. Ed. 2009, 48, 5094. (e)
Lyons, T. W.; Sanford, M. S. Chem. Rev. 2010, 110, 1147. (f) Daugulis,
O. Top. Curr. Chem. 2010, 292, 57. (g) Chiusoli, G. P.; Catellani, M.;
Costa, M.; Motti, E.; Ca’, N. D.; Maestri, G. Coord. Chem. Rev. 2010,
254, 456.
(2) (a) Chen, X.; Goodhue, C. E.; Yu, J.-Q. J. Am. Chem. Soc. 2006,
128, 12634. (b) Giri, R.; Maugel, N.; Li, J.-J.; Wang, D. H.; Breazzano,
S. P.; Saunders, L. B.; Yu, J.-Q. J. Am. Chem. Soc. 2007, 129, 3510. (c)
Wang, D.-H.; Wasa, M.; Giri, R.; Yu, J.-Q. J. Am. Chem. Soc. 2008, 130,
7190. (d) Dai, H.-X.; Stepan, A. F.; Plummer, M. S.; Zhang, Y.-H.; Yu,
J.-Q. J. Am. Chem. Soc. 2011, 133, 7222. (e) Romero-Revilla, J. A.;
Garcia-Rubia, A.; Arrayas, R.; Fernandez-Ibanez, M. A.; Carretero,
J. C. J. Org. Chem. 2011, 76, 9525. (f) Wasa, M.; Engle, K. M.; Lin,
D. W.; Yoo, E. J.; Yu, J.-Q. J. Am. Chem. Soc. 2011, 133, 19598. (g)
Wasa, M.; Chan, K. S. L.; Yu, J.-Q. Chem. Lett. 2011, 40, 1004.
(3) CꢀH alkylation with alkylstannanes: Chen, X.; Li, J.-J.; Hao,
X.-S.; Goodhue, C. E.; Yu, J.-Q. J. Am. Chem. Soc. 2006, 128, 78.
(4) CꢀH methylation with MeI: Tremont, S. J.; Rahman, H. U.
J. Am. Chem. Soc. 1984, 106, 5759.
(5) CꢀH alkylation with alkyl halides: (a) Catellani, M.; Frignani,
F.; Rangoni, A. Angew. Chem., Int. Ed. 1997, 36, 119. (b) Rudolph, A.;
Rackelmann, N.; Lautens, M. Angew. Chem., Int. Ed. 2007, 46, 1485. (c)
Zhang, Y.-H.; Shi, B.-F.; Yu, J.-Q. Angew. Chem., Int. Ed. 2009, 48,
6097. (d) Shabashov, D.; Daugulis, O. J. Am. Chem. Soc. 2010, 132,
3965. (e) Zhao, Y.; Chen, G. Org. Lett. 2011, 13, 4850. (f) Tran, L. D.;
Daugulis, O. Angew. Chem., Int. Ed. 2012, 51, 5188. (g) Zhang, S. Y.; He,
G.; Nack, W. A.; Zhao, Y.; Li, Q.; Chen, G. J. Am. Chem. Soc. 2013, 135,
2124.
These limitations are due, in large part, to the reaction
mechanism, which is believed to involve (i) ligand-directed
CꢀH activation at PdII, (ii) transmetalation from boron to
PdII, (iii) CꢀC reductive elimination from PdII, and (iv)
(6) CꢀH methylation with TBHP: Zhang, Y.; Feng, J.; Li, C.-J.
J. Am. Chem. Soc. 2008, 130, 2900.
(7) (a) Darses, S.; Genet, J.-P. Chem. Rev. 2008, 108, 288. (b)
Molander, G. A.; Sandrock, D. L. Curr. Opin. Drug Discovery Dev.
2009, 12, 811.
r
10.1021/ol400888r
XXXX American Chemical Society